ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
AstraZeneca is assuming full ownership of its subsidiaries in India and Japan. In India, AstraZeneca is moving to acquire the 25% of AstraZeneca Pharma India, which is listed on the Bombay Stock Exchange, that it doesn’t already own. The Indian unit reported sales of $63 million in its latest fiscal year. In Japan, AstraZeneca will acquire the 20% stake in its Japanese subsidiary now owned by Sumitomo Chemical.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter